These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15796299)

  • 1. Statistical inference for relative potency in bivariate dose-response assays with correlated responses.
    Iturria SJ
    J Biopharm Stat; 2005; 15(2):343-51. PubMed ID: 15796299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian design and analysis for dose-response using informative prior information.
    Smith MK; Marshall S
    J Biopharm Stat; 2006; 16(5):695-709. PubMed ID: 17037266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized calculation of biological potency: presentation of the interactive computer program "POTENCY" (assays: "2 + 2" doses, "3 + 3" doses, "twin cross-over assay" and "probit analysis" ("2 + 2" doses).
    Arambasić MB
    Boll Chim Farm; 2001; 140(6):433-9. PubMed ID: 11822234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shared response model for clustered binary data in developmental toxicity studies.
    Pang Z; Kuk AY
    Biometrics; 2005 Dec; 61(4):1076-84. PubMed ID: 16401281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of different bivariate correlated frailty models and estimation strategies.
    Wienke A; Arbeev KG; Locatelli I; Yashin AI
    Math Biosci; 2005 Nov; 198(1):1-13. PubMed ID: 16185720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlated measurement error--implications for nutritional epidemiology.
    Day NE; Wong MY; Bingham S; Khaw KT; Luben R; Michels KB; Welch A; Wareham NJ
    Int J Epidemiol; 2004 Dec; 33(6):1373-81. PubMed ID: 15333617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inference methods for saturated models in longitudinal clinical trials with incomplete binary data.
    Song JX
    Pharm Stat; 2006; 5(4):295-304. PubMed ID: 17128429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalence testing for parallelism in the four-parameter logistic model.
    Jonkman JN; Sidik K
    J Biopharm Stat; 2009 Sep; 19(5):818-37. PubMed ID: 20183446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
    Brannath W; Bretz F; Maurer W; Sarkar S
    Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal likelihood inference for a model for item responses and response times.
    Glas CA; van der Linden WJ
    Br J Math Stat Psychol; 2010 Nov; 63(Pt 3):603-26. PubMed ID: 20109271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
    Thomas N
    J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixture models for continuous data in dose-response studies when some animals are unaffected by treatment.
    Boos DD; Brownie C
    Biometrics; 1991 Dec; 47(4):1489-504. PubMed ID: 1786327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive modelling of dose-response relationships using smoothing splines.
    Kirby S; Colman P; Morris M
    Pharm Stat; 2009; 8(4):346-55. PubMed ID: 19205006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to evaluate regression models during validation of bioanalytical assays.
    Singtoroj T; Tarning J; Annerberg A; Ashton M; Bergqvist Y; White NJ; Lindegardh N; Day NP
    J Pharm Biomed Anal; 2006 Apr; 41(1):219-27. PubMed ID: 16332425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.
    Carr GJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):779-91. PubMed ID: 8241373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivariate line-fitting methods for allometry.
    Warton DI; Wright IJ; Falster DS; Westoby M
    Biol Rev Camb Philos Soc; 2006 May; 81(2):259-91. PubMed ID: 16573844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.